Found 6 matching trials
Study to Assess Safety and Activity of Combination Therapy of VRC07-523LS and Vorinostat on HIV-infected Persons
PHASE1Adult participants (18-64 years old) with HIV-1 Infection on ART with a CD4...
Location
University of North Carolina Health Care
Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer
PHASE2This will be a randomized phase II clinical trial of patients with histolog...
Location
Cancer Therapy and Research Center University of Texas Health Science Center San Antonio
Study to Evaluate Effects of Vorinostat and HXTC on Persistent HIV-1 Infection in HIV-Infected Subjects Started on Antiretroviral Therapy (ART)
PHASE1This is a phase I, single-site, study to evaluate the effects of VOR and HI...
Location
University of North Carolina at Chapel Hill
Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
PHASE1The purpose of this research study is to 1) evaluate the safety of a series...
Location
University of North Carolina Hospitals
The DART DELIVER-02 Study
PHASE1This research study aims to find out how safe and well tolerated the experi...
Location
University of North Carolina
The Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ART
PHASE1The purpose of this study is to compare HIV RNA expression and infection wi...
Location
The University of North Carolina at Chapel Hill